Actively Recruiting
Press Needle on Body Acupuncture Points and Auricular Acupuncture Points on Functional Dyspepsia
Led by Indonesia University · Updated on 2025-10-07
38
Participants Needed
1
Research Sites
44 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study was to prove that press needle (PN) and medication are more effective in reducing symptoms and improving quality of life in people with functional dyspepsia compared to sham press needle (Sham PN) and medication. The main questions this study aims to answer are: * Does the press needle and medication group reduce symptoms in people with functional dyspepsia as assessed by the Short Form-Leeds Dyspepsia Questionnaire (SF-LDQ) compared to the sham press-needle and medication group on days 7 and 14, compared to before therapy? * Does the press-needle and medication group improve quality of life in people with functional dyspepsia as assessed by the Short-Form Nepean Dyspepsia Index (SF-NDI) compared to the sham press-needle and medication group on days 7 and 14, compared to before therapy? A total of 38 participants were randomly allocated into two groups, either PN or Sham PN needle groups Participants will: * Receive PN or Sham PN for 14 days and replaced on day 7. * Complete the SF-LDQ and SF-NDI questionnaires before therapy, on day 7, and day 14.
CONDITIONS
Official Title
Press Needle on Body Acupuncture Points and Auricular Acupuncture Points on Functional Dyspepsia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 18-59 years
- Diagnosed with functional dyspepsia
- Esophagogastroduodenoscopy (EGD) shows no significant structural abnormalities or no structural abnormalities
- Willing to participate until study completion and sign informed consent
You will not qualify if you...
- Inflammation, malignancy, or scar tissue present at acupuncture point locations
- Deformity of the earlobe
- History of allergy to stainless steel or plaster
- Medical emergencies, impaired consciousness, pregnancy, history of diabetes mellitus, or history of keloid formation
- History of digestive tract cancer, hepatobiliary cancer, chronic kidney failure stage 4 or 5, hyperthyroidism, or hypothyroidism
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universitas Indonesia
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
Actively Recruiting
Research Team
M
Maria Anastasia Darmawan, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here